Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -6.05 is 63% above its 5-year average of -16.51, near the high end of its 5-year range (-74.20–-2.08).
85.92% above its 12-month average of -42.97.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.90.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 11 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:38:21.912Z. Historical observations retain their original dates. Historical series through 2024-08-14.
EARNINGS PER SHARE (EPS)
-6.05
EARNINGS PER SHARE (EPS) AVG TTM
-42.97
EARNINGS PER SHARE (EPS) AVG 3Y
-23.50
EARNINGS PER SHARE (EPS) AVG 5Y
-16.51
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+85.92%
CURRENT VS 3Y AVG
+74.26%
CURRENT VS 5Y AVG
+63.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
60 Degrees Pharmaceuticals, Inc.
Market Cap
$3.85M
Earnings Per Share (EPS)
-6.05
TTM Avg
-42.97
3Y Avg
-23.50
5Y Avg
-16.51
Market Cap
$3.74M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.97M
Earnings Per Share (EPS)
-211.18
TTM Avg
-432751.00
3Y Avg
-875189.50
5Y Avg
-22462429.83
Market Cap
$3.62M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.61M
Earnings Per Share (EPS)
-18.85
TTM Avg
-47.63
3Y Avg
-99.69
5Y Avg
-316.96
Market Cap
$4.11M
Earnings Per Share (EPS)
-5.60
TTM Avg
-53.55
3Y Avg
-292.57
5Y Avg
-468.76
Market Cap
$3.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-37.01
3Y Avg
-21.04
5Y Avg
-1.64
Market Cap
$4.13M
Earnings Per Share (EPS)
N/A
TTM Avg
-60.73
3Y Avg
-46926.80
5Y Avg
-32538.00
Market Cap
$3.55M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | $3.85M | -6.05 | -42.97 | -23.50 | -16.51 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.74M | -4.90 | -7.69 | -8.41 | -8.41 |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.97M | -211.18 | -432751.00 | -875189.50 | -22462429.83 |
| Evogene Ltd. (EVGN)vs › | $3.62M | -0.91 | -1.99 | -3.92 | -2.83 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.61M | -18.85 | -47.63 | -99.69 | -316.96 |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | -5.60 | -53.55 | -292.57 | -468.76 |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.58M | N/A | -37.01 | -21.04 | -1.64 |
| GRI Bio, Inc. (GRI)vs › | $4.13M | N/A | -60.73 | -46926.80 | -32538.00 |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | -14.40 | -19.95 | -16.43 | -17.45 |
| Eocene Ltd. (EOCN)vs › | $3.54M | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$-6.05
Forward EPS (Est.)
$-3.16
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -11.73 |
| 2024-12-31 | -74.20 |
| 2023-12-31 | -3.80 |
| 2022-12-31 | -4.28 |
| 2021-12-31 | -2.96 |
| 2020-12-31 | -2.08 |
